Clincosm LogoSign in Get a demo

advanced renal cell carcinoma

Showing 1 - 25 of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

Recruiting
  • Advanced Renal Cell Carcinoma
  • ST-1898 tablets
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Nov 6, 2023

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

Recruiting
  • Advanced Colorectal Carcinoma
  • +15 more
  • Fermented Wheat Germ Extract
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jul 26, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)

Not yet recruiting
  • Advanced Renal Cell Carcinoma
  • (no location specified)
Jun 23, 2023

Solid Tumor, Adult, Advanced Solid Tumor, Advanced Renal Cell Carcinoma Trial in Australia (89Zr-TLX250, 177Lu-TLX250 and

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • 89Zr-TLX250
  • 177Lu-TLX250 and Peposertib
  • North Ryde, New South Wales, Australia
  • +4 more
May 22, 2023

Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

Recruiting
  • Advanced Ovarian Carcinoma
  • +7 more
  • Bydgoszcz, Kujawsko-pomorskie, Poland
  • +2 more
Mar 7, 2023

Advanced Renal Cell Carcinoma, Advanced Mesothelioma, Advanced Osteosarcoma Trial in Houston (CAR.70/IL15-transduced CB-derived

Not yet recruiting
  • Advanced Renal Cell Carcinoma
  • +2 more
  • CAR.70/IL15-transduced CB-derived NK cells
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 24, 2023

Collect Pre-existing Data on Administration of Cabozantinib in

Recruiting
  • Advanced Renal Cell Carcinoma
    • Amiens, France
    • +27 more
    Dec 26, 2022

    Metastatic Melanoma, Metastatic Breast Cancer, Advanced Renal Cell Carcinoma Trial in Worldwide (single arm)

    Withdrawn
    • Metastatic Melanoma
    • +5 more
    • single arm
    • (no location specified)
    Dec 20, 2022

    Advanced Renal Cell Carcinoma Trial in Heilbronn (IVAC)

    Recruiting
    • Advanced Renal Cell Carcinoma
    • IVAC
    • Heilbronn, Germany
      SLK Kliniken Heilbronn, Klinik für Innere Medizin III: Hämatolog
    Nov 30, 2022

    Cabozantinib in Combination With Nivolumab as First-line

    Recruiting
    • Advanced Renal Cell Carcinoma
      • Angers, France
      • +42 more
      Dec 1, 2022

      Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

      Recruiting
      • Advanced Clear Cell Renal Cell Carcinoma
      • +11 more
      • Cabozantinib S-malate
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Nov 22, 2022

      ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

      Recruiting
      • ccRCC
      • +9 more
      • Oral NKT2152
      • Scottsdale, Arizona
      • +6 more
      Oct 17, 2022

      Advanced Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Duarte (Clostridium

      Active, not recruiting
      • Advanced Renal Cell Carcinoma
      • +5 more
      • Clostridium butyricum CBM 588 Probiotic Strain
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Oct 12, 2022

      Advanced Renal Cell Carcinoma Trial in United States (Dalantercept and axitinib, Placebo and axitinib)

      Terminated
      Has Results
      • Advanced Renal Cell Carcinoma
      • Dalantercept and axitinib
      • Placebo and axitinib
      • Tucson, Arizona
      • +35 more
      Sep 12, 2022

      Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

      Recruiting
      • Advanced Bladder Carcinoma
      • +34 more
      • Atezolizumab
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 29, 2022

      And Use Of Avelumab In Combination With Axitinib For Treatment

      Recruiting
      • Advanced Renal Cell Carcinoma
      • Sandwich, Kent, United Kingdom
        Pfizer Ltd
      May 23, 2022

      Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,

      Recruiting
      • Advanced Breast Carcinoma
      • +73 more
      • Atezolizumab
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      May 5, 2022

      Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

      Recruiting
      • Advanced Differentiated Thyroid Gland Carcinoma
      • +102 more
      • Cabozantinib S-malate
      • Nivolumab
      • Chicago, Illinois
      • +2 more
      Apr 5, 2022

      Advanced Renal Cell Carcinoma Trial in Spain (Pazopanib + interferon alpha 2A)

      Completed
      • Advanced Renal Cell Carcinoma
      • Pazopanib + interferon alpha 2A
      • Hospitalet de Llobregat, Barcelona, Spain
      • +12 more
      Mar 9, 2022

      Advanced Renal Cell Carcinoma Trial (QL1706 Plus Lenvatinib)

      Not yet recruiting
      • Advanced Renal Cell Carcinoma
      • QL1706 Plus Lenvatinib
      • (no location specified)
      Feb 21, 2022

      Clear Cell Renal Cell Carcinoma, Kidney Cancer, Advanced Renal Cell Carcinoma Trial in United States

      Recruiting
      • Clear Cell Renal Cell Carcinoma
      • +2 more
      • Basking Ridge, New Jersey
      • +6 more
      Feb 16, 2022

      Advanced Renal Cell Carcinoma Trial in United States (Nivolumab 240 mg, Ipilimumab 1mg/kg, Nivolumab 3mg/kg)

      Recruiting
      • Advanced Renal Cell Carcinoma
      • Nivolumab 240 mg
      • +3 more
      • New Haven, Connecticut
      • +11 more
      Feb 14, 2022

      Advanced Renal Cell Carcinoma Trial in United States (CMN-001, Nivolumab+Ipilimumab, Lenvatinib+Everolimus)

      Recruiting
      • Advanced Renal Cell Carcinoma
      • CMN-001
      • +2 more
      • Tampa, Florida
      • +6 more
      Feb 10, 2022